3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Ovarian Neoplasms
2
Carcinoma, Transitional Cell
2
Triple Negative Breast Neoplasms
1
Rectal Neoplasms
1
Neoplasms
1
Muscle Invasive Bladder Cancer (MIBC)
1
Head and Neck Neoplasms
1
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
1
HER2-low Breast Cancer
1
Gastric Adenocarcinoma
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Advanced Breast Cancer
1
Interventions
tucatinib
1
pertuzumab
1
atezolizumab
1
Trastuzumab
1
Fulvestrant
1
Alpelisib
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HER2-positive Metastatic Breast Cancer
×
disitamab vedotin
×
1 year
×
Clear all
No trials found.